Hydrocortisone acetate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrocortisone acetate and what is the scope of freedom to operate?
Hydrocortisone acetate
is the generic ingredient in nineteen branded drugs marketed by Mylan Speciality Lp, Fougera Pharms, Able, Cenci, Imperium, Parke Davis, Purepac Pharm, Sebela Ireland Ltd, Taro, Pharmacia And Upjohn, Pfizer, Bel Mar, Epic Pharma Llc, Watson Labs, Merck, Ingram Pharm, Fera Pharms, Colgate, X Gen Pharms, Monarch Pharms, Genus, and Ferndale Labs, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.There are fourteen drug master file entries for hydrocortisone acetate. Two suppliers are listed for this compound.
Summary for hydrocortisone acetate
US Patents: | 0 |
Tradenames: | 19 |
Applicants: | 22 |
NDAs: | 40 |
Drug Master File Entries: | 14 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 20 |
Patent Applications: | 7,082 |
Drug Prices: | Drug price trends for hydrocortisone acetate |
What excipients (inactive ingredients) are in hydrocortisone acetate? | hydrocortisone acetate excipients list |
DailyMed Link: | hydrocortisone acetate at DailyMed |
Recent Clinical Trials for hydrocortisone acetate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Merck Sharp & Dohme LLC | Phase 1 |
Orion Corporation, Orion Pharma | Phase 1 |
University Medical Center Groningen | Early Phase 1 |